Accordingly, TAMs promote the upregulation of cluster of differentiation 47 (CD47) ligand on different cancers stem cells (including pancreatic, HCC and leukemia), which interacts to signal-regulatory protein alpha (SIRPA) on immune cells inhibiting phagocytic process (205–207). The gene discussed is SIRPA; the disease is hepatocellular carcinoma.